Burrill & Company

Burrill & Company is a diversified global financial services firm specializing in the life sciences sector. Founded in 1994, the firm manages over $1.5 billion in assets, encompassing venture capital, private equity, merchant banking, and media operations. By leveraging its team's scientific and business networks, Burrill & Company offers unparalleled access and visibility in the life sciences industry. This unique combination of resources enables the firm to provide capital, transactional support, management expertise, insight, market intelligence, and analysis through its investments, conferences, and publications. Headquartered in San Francisco, the company oversees a global network of offices throughout the United States, Latin America, Europe, and Asia.

The firm's investment strategy focuses on sectors such as biotechnology, pharmaceuticals, medical devices, healthcare, information technology, agriculture, materials, water and clean technology, and energy. Burrill & Company invests across various stages, including early stage, growth, late stage, pre-IPO, buyout, turnaround, and distressed situations. Geographically, the firm has a presence in the United States, China, Europe, Asia, and Latin America.

Burrill & Company has a track record of strategic partnerships, such as its joint venture with Infinity Group to pursue life science investment opportunities in China. This collaboration combines Burrill & Company's global experience with Infinity's extensive network in China, enhancing their ability to bring innovative technologies to the Chinese market. The firm's comprehensive approach and strategic alliances underscore its commitment to advancing the life sciences industry through diverse investment avenues and global partnerships.